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Objectives: Emergency room visits by nursing home patients with bloodstream infections (BSIs) are not
uncommon and pose challenges to clinicians when selecting appropriate antimicrobial agents. This
research aims to discover distinct bacteriology in nursing home patients by focusing particularly on
antimicrobial-resistant bacteria.
Methods: This retrospective study enrolled patients aged 65 years or older who had documented positive
blood culture reports between May 2006 and June 2008. Patients were further categorized into
subgroups according to nursing home history and the timely trend of hospital exposure.
Results: The adjusted risk of BSIs associated with nursing home exposure was signiﬁcantly higher in
Methicillin-resistant Staphylococcus aureus (odds ratio (OR) 2.0; 95% CI 1.5e2.8), Methicillin-resistant
coagulase-negative Staphylococcus species (OR 1.7; 95% CI 1.2e2.5), and Enterobacteriaceae-extended
spectrum b-lactamase-producing Enterobacteriaceae (OR 2.4; 95% CI 1.5e3.9), but not in Pseudomonas
aeruginosa (OR 1.4; 95% CI 0.9e2.2) or Acinetobacter baumannii (OR 0.9; 95% CI 0.5e1.5).
Conclusion: Host environmentsdnursing home or hospital exposuredwere shown to be more signiﬁcant
than medical comorbid conditions for acquiring antimicrobial-resistant pathogens. Each unique envi-
ronment increased the risk for acquiring some pathogens, but not all. In addition, these environmental
factors may also exert cumulative effects toward some speciﬁc pathogens.
Copyright  2012, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Bloodstream infections (BSIs) have potential risks of rapid
deterioration, prolonged hospital stay and increased mortality if
untreated or when treatment is delayed1,2. Selection of appropriate
antimicrobial agents is critical and urgent for patients with sus-
pected BSIs as emergency room (ER) physicians face the challenge of
determining which to use, especially if antimicrobial-resistant
pathogens are taken into consideration. Although the early use of
broad-spectrum antibiotics for serious infections in the emergency
setting is recommended, treatment failures by such regimens showerest.
gency Department, Mackay
Road, Taipei, Taiwan.
ang).
iwan Society of Geriatric Emergenan increased rate and are associated with rapid emergence and
spread of antimicrobial-resistance bacteria (ARB), which exert
resistance to empirical antibiotics. For example, use of broad-
spectrum b-lactam antibiotic therapy in septic patients may
provide antimicrobial effects on a wide spectrum of pathogens
but not against the growing numbers of ARB strains, such as
Methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas
spp and Enterobacteriaceae-extended spectrum b-lactamase (ESBL)-
producing Enterobacteriaceae.
Currently, there are no published practical guidelines on BSIs
with attention to ARB for ER physicians to follow at the initial
management of suspected cases. ER physicians generally select
antimicrobial regimens on the basis of the subtleties of a patient’s
clinical status, as well as the physician’s experience and preferences
in clinical practice, leaving the risk-and-beneﬁt assessment of
whether to include ARB-targeted antibiotics in the treatment
a subjective choice.cy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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such as medical history and environmental exposure3e5. Most
studies classiﬁed patients into infection groups of community or
hospital acquired, which sheds light on possible cause of infection
strains when dealing with a difﬁcult selection among antibiotics.
The likelihood of infections byan ARB strain is substantially lower in
community-acquired cases and higher in hospital-acquired infec-
tions. More recently, some studies5e7 have proposed that patients
with health-care-associated BSIs should be considered as a special
group, separate from patients with community- or hospital-
acquired BSIs. However, in these studies, health-care-associated
infections represented a non-speciﬁc group of patients with very
different housing arrangements; it included nursing homes that
provided health care to regular home residentswith end-stage renal
diseasewhoneeded tovisit outpatientunits, suchasdialysis centers.
We propose that nursing homes represent a unique environment,
with BSIs bacteriology different than that of outpatient units8.
The incidence of bacteremia in nursing home patients ranges
from ﬁve to 40 episodes in every 100,000 resident-days, but the
mortality is as high as 18e24%8,9. Advanced age concomitant with
various underlying medical diseases might be responsible; never-
theless, it is the authors’ view that the nursing home is a distinct
environment with speciﬁc strains of organisms including drug-
resistant pathogens that deserve special attention. To our knowl-
edge, few studies have reported the epidemiology of BSIs in nursing
home, but limited studies have addressed the prevalence of
common drug-resistant bacteria associated with nursing homesda
key factor when deciding appropriate antibiotic treatment. We
hypothesize that nursing home residency is an independent risk
factor for BSIs with particular antibiotic resistance strains8.
This study aimed to discover the distinct bacteriology in nursing
home patients, by focusing on common ARB strains in terms of rela-
tionships among the ARB, co-morbidities, and the interactions
betweenthehostenvironments,nursinghomeandhospitalexposure.
2. Methods
2.1. Study setting and data collection
We conducted this retrospective study in a 1100-bed urban
medical center in Taipei, Taiwan, which reports more than 160,000
annual ER visits and serves as a referral hospital for several regional
nursing care facilities. The study enrolled patients aged 65 years or
more who had documented positive blood culture reports between
May 2006 and June 2008. The signiﬁcance of bacteriologic data was
determined by a combination of medical history, clinical course and
the results of laboratory and other diagnostic tests.
Information about underlying comorbid medical conditions
that may increase the risk of development of bacteremia was recor-
ded3,5,10,11, including diabetes, cerebrovascular disease, liver cirrhosis,
the presence of active cancer and bedridden status. Certain factors
that may predispose to infection12,13, such as end-stage renal disease
requiring regular hemodialysis, malignancies or active parenteral
chemotherapy, were also obtained through medical record review.
2.2. Bacteriologic method
All blood cultures were obtained following standard hospital
protocol, which includes two sets of culture drawn at separate
sites, with each set of blood culture consisting of a pair of aerobic
and anaerobic FAN bottles, containing culture medium to enhance
the recovery of micro-organisms (Organon Teknika Corporation,
Durham, NC). We processed identiﬁcation of microorganisms and
determined antibiotic susceptibility using the VITEK2 systems
(BioMérieux, Marcy l'Etoile, France).2.3. Study design and deﬁnition
An episode of positive blood culture was deﬁned by the ﬁrst set
of positive blood cultures on presentation or during hospital
admission and was considered the same episode if serial blood
culture was obtained within 48 h of the previous blood culture.
All positive blood culture data were classiﬁed as 1) true BSIs, 2)
clinically insigniﬁcant, or 3) contamination. Common skin ﬂora
yielded by single blood culture were excluded as contamination14,
and any episode was considered missing when information was
incomplete. A true episode of BSI was deﬁned as at least one set
of positive blood culture regardless of mono- or poly-microbial
infection in patients with clinically systemic inﬂammatory
response syndrome14. All true BSI episodes were further grouped
according to history of nursing home exposure and timely trend of
hospital exposure (Fig. 1):
1. “Non-Nursing home Group” (nNH) included BSIs that occurred
in patients with no nursing home exposure and episodes of BSI
that occurred within the ﬁrst 48 h of hospital admission;
2. “Non-Nursing home with re-hospitalization Group” (nNH-reH)
consisted of BSIs in non-nursing home residents whose BSI
episodes developed within the ﬁrst 48 h of re-hospitalization
and who had been hospitalized in the previous 30 days.
3. “Nursing home Group” (NH) included BSIs that occurred in
nursing home residents who developed BSI within the ﬁrst
48 h of hospitalization.
4. “Nursing home with re-hospitalization Group” (NH-reH) con-
sisted of nursing home residents with BSI episodes within 48 h
of re-hospitalization and who had been hospitalized in the
previous 30 days.
5. “Hospital-acquired Group” (HA) included patients with BSI
episodes evident 48 h after hospital admission or patients
transferred from another hospital with known episodes of BSI.
All episodes of BSIs in this group were nosocomial infections15.
Out of clinical interest, various drug-resistant pathogens were
especially selected for analysis, including MRSA, Methicillin-
resistant coagulase-negative Staphylococcus species (MRCNS),
ESBLs, Pseudomonas aeruginosa and Acinetobacter baumannii. All
ESBL-producing Enterobacteriaceae including Escherichia coli,
Enterobacter cloacae, Klebsiella pneumoniae and Proteus mirabilis
were pooled for analysis16,17.
2.4. Statistical analysis
We compared the odds ratios (ORs) for selected pathogens
between ﬁve patient groups by specifying nNH as the baseline
group. Univariable analysis between categorical variables and the
probability of acquiring BSIs by selected pathogens was evaluated
by contingency table. Chi-square test or Fisher’s exact test was
applied as appropriate. The OR for patients with and without
certain exposure and the corresponding 95% conﬁdence interval
(CI) was obtained. Hospital exposure factor was further categorized
into three levels: the ﬁrst level consisted of BSIs occurring before or
within the ﬁrst 48 h of hospitalization; the second level included
the same criteria as the ﬁrst level in addition to the presence of
hospitalization within the past 30 days; and the third level con-
sisted of BSIs developed after 48 h of hospitalization. The ﬁrst level
was used for reference. Variables that were signiﬁcant in uni-
variable analysis were included in the multivariable regression
model, and a stepwise method was adopted to select signiﬁcant
variables in the ﬁnal overall model. In addition, the signiﬁcance
level set at p< 0.05, and all analyses were performed using SAS
software version 9.1 (SAS institute Inc, Cary, NC, USA).
Table 1
Demographics and medical comorbid disorder for all groups.
NH NH-reH nNH nNH-reH HA
n (%) n (%) n (%) n (%) n (%)
Age (mean, SD) 78.0 (7.5) 77.8 (7.2) 81.0 (7.0) 80.5 (6.4) 78.7 (7.3)
Male gender 177 44.3 52 55.3 82 43.2 33 56.9 289 53.9
Diabetes mellitus 136 34.0 43 45.7 69 36.3 23 39.7 194 36.2
End-stage renal disease 14 3.5 3 3.2 14 7.4 4 6.9 65 12.1
Bedridden 64 16.0 20 21.3 100 52.6 30 51.7 148 27.6
Stroke 119 29.8 29 30.9 103 54.2 32 55.2 135 25.2
Liver cirrhosis 27 6.8 3 3.2 5 2.6 1 1.7 50 9.3
Solid organ malingnancy 65 16.3 38 40.4 24 12.6 12 20.7 228 42.5
Haemotologic malignancy 4 1.0 3 3.2 1 0.5 1 1.7 10 1.9
Chemotherapy 2 0.5 10 10.6 1 0.5 3 5.2 39 7.3
Percentage(%) represent patient number divided by total patient number in each group.
Fig. 1. Study algorithm and the corresponding patient numbers, episodes and isolated pathogens in each group.
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Table 2
Microbiology for all groups.
nNH nNH-reH NH NH-reH HA
n (%) n (%) n (%) n (%) n (%)
Selected Gram-positive strains
Staphylococcus aureus 45 (8.30) 28 (18.92) 34 (11.64) 17 (17) 151 (18.26)
MRSA 18 (3.32) 19 (12.84) 28 (9.59) 14 (14) 127 (15.36)
MSSA 27 (4.98) 9 (6.08) 6 (2.05) 3 (3) 24 (2.9)
Coagulase-negative Staphylococcus 35 (6.46) 15 (10.14) 34 (11.64) 18 (18) 44 (5.32)
MRCNS 25 (4.61) 14 (9.46) 31 (10.62) 17 (17) 43 (5.2)
MSCNS 10 (1.85) 1 (0.68) 3 (1.03) 1 (1) 1 (0.12)
Streptococcus species 61 (11.25) 10 (6.76) 20 (6.85) 1 (1) 7 (0.85)
Enterococcus species 20 (3.69) 6 (4.05) 13 (4.45) 5 (5) 39 (4.72)
Peptostreptococcus species 14 (2.58) 0 (0) 4 (1.37) 1 (1) 4 (0.48)
b -hemolysis streptococcus group B 9 (1.66) 2 (1.35) 7 (2.4) 1 (1) 3 (0.36)
Selected Gram-negative strains
Escherichia coli 176 (32.47) 35 (23.65) 78 (26.71) 14 (14) 81 (9.79)
Non-ESBLs 169 (31.18) 35 (23.65) 60 (20.55) 9 (9) 71 (8.59)
ESBLs 7 (1.29) 0 (0) 18 (6.16) 5 (5) 10 (1.21)
Klebsiella pneumoniae 53 (9.78) 14 (9.46) 19 (6.51) 10 (10) 98 (11.85)
Non-ESBLs 51 (9.41) 12 (8.11) 15 (5.14) 4 (4) 58 (7.01)
ESBLs 2 (0.37) 2 (1.35) 4 (1.37) 6 (6) 40 (4.84)
Acinetobacter baumannii 1 (0.18) 3 (2.03) 1 (0.34) 3 (3) 82 (9.92)
Pseudomonas aeruginosa 6 (1.11) 9 (6.08) 7 (2.4) 8 (8) 63 (7.62)
Bacteroides fragilis group 16 (2.95) 5 (3.38) 4 (1.37) 1 (1) 9 (1.09)
Proteus mirabilis 16 (2.95) 4 (2.7) 12 (4.11) 2 (2) 8 (0.97)
Serratia marcescens 5 (0.92) 2 (1.35) 5 (1.71) 1 (1) 29 (3.51)
Percentage(%) derived by dividing numbners of isolated by toatal numbers of isolated in each group.
Abbreviations: MRSA, Methicillin-resistant Staphylococcus aureus; MSSA, Methicillin-sensitive Staphylococcus aureus; MRCNS, Methicillin-resistant coagulase-negative
Staphylococcus; MSCNS, Methicillin-sensitive coagulase-negative Staphylococcus; ESBLs, Extended spectrum ß-lactamases.
Streptococcus species includes all pathogenic Streptococcus except S. pneumoniae, S. agalactiae, S. pyogenes and S. viridans.
Enterococcus species includes all pathogenic Enterococcus.
Peptostreptococcus species includes all pathogenic Peptostreptococcus.
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3.1. Population and demographics
The study included a total of 2528 episodes of positive blood
cultures taken betweenMay 2006 and June 2008. The vast majority
of pathogens among the 820 episodes of contamination were
coagulase-negative Staphylococcus species (85.2%) and Corny-
bacterum (11.8%). Aside from ﬁve missing episodes and 17 episodes
of unknown clinical signiﬁcance, a total of 1686 consecutive
episodes were identiﬁed as true BSIs, of which 482 (28.6%) episodes
were classiﬁed as group nNH, 132 (7.8%) as group nNH-reH, 252
(15.0%) as group NH, 89 (5.3%) as group NH-reH, and 731 (43.4%) as
group HA. Fig. 1 shows the corresponding patient numbers,
episodes and isolated pathogens in each subgroup.
The mean age of the patients in each group was similar
(Table 1); however, it was signiﬁcantly higher in group NH and NH-
reH and refers to all nursing home patients. In addition, both stroke
and bedridden status were higher in the nursing home populations.Table 3
Odds ratio of selected resistant strains in all groups.
nNH nNH-reH
OR OR (95% CI) OR
Gram(þ)
MRSA 1 4.30 (2.19-8.42) 3.09
MRCNS 1 2.17 (1.10-4.28) 2.46
Gram(-)
P. Aeruginosa 1 5.79 (2.03-16.55) 2.20
ESBLsa 1 0.73 (0.16-3.37) 4.77
A. baumannii 1 11.21 (1.16-108.59) 1.86
Abbreviations: MRSA, Methicillin-resistant Staphylococcus aureus; MRCNS, Methicillin-re
a Enterobacteriaceae-ESBLs include: E. coli, Enterobacter cloacae, Klebsiella pneumoniae,3.2. Pathogens and selected resistant strains
Table 2 shows microbiological data for all groups. Gram-
negative pathogens accounted for most of the BSIs in every
group. In addition, E. coli was the top-listed pathogen responsible
for BSIs in patients in three groups (nNH, nNH-reH and NH);
however, in two groups (NH-reH and HA), the most responsible
pathogens were MRCNS and MRSA, respectively.
Table 3 shows the OR of bacteremia caused by the selected ﬁve
resistant pathogens in patients of each group relative to the nNH
group. This is also demonstrated in Fig. 2, using log value for each
OR. An upward curve in Fig. 2A showed the OR of BSIs resulting
from MRSA, P. aeruginosa, and A. baumannii gradually increased
in an environmental-oriented fashion, from the reference group
(nNH) to the hospital-acquired group at each end. Nevertheless,
Fig. 2B showed an M-shaped curve among the groups, revealing
an especially higher OR of acquiring ESBL-producing Enter-
obacteriaceae and MRCNS in all nursing home patients (both NH
and NH-reH groups).NH NH-reH HA
(95% CI) OR (95% CI) OR (95% CI)
(1.68-5.70) 4.75 (2.28-9.90) 5.29 (3.19-8.78)
(1.42-4.26) 4.24 (2.20-8.20) 1.14 (0.69-1.88)
(0.73-6.60) 7.78 (2.64-22.94) 7.38 (3.17-17.17)
(2.25-10.13) 6.59 (2.72-15.97) 3.50 (1.76- 6.96)
(0.12-29.88) 16.76 (1.73-162.80) 59.65 (8.28-429.86)
sistant coagulase-negative Staphylococcus; ESBLs, Extended spectrum ß-lactamases.
Proteus mirabilis.
Fig. 2. The log value of odds ratios in selected resistant pathogens for all groups; the non-nursing home group was used as the reference group. Two different patterns were shown
in plot (A) and (B) by different pathogens.
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Univariable and multivariable analyses were performed for
selected resistant strains and the results are shown in Table 4.
Neither age nor sex was statistically signiﬁcant, and only a few
comorbid medical conditions were associated with increased risk
for bacteremia, yet were varied in each ARB. After adjusting for
hospital exposure factors and medical comorbid conditions, the
risk of BSIs associated with the presence of nursing home exposure
was signiﬁcantly higher in MRSA (OR 2.0, 95% CI 1.5e2.8), MRCNS
(OR 1.7, 95% CI 1.2e2.5), and ESBL-producing Enterobacteriaceae
(OR 2.4, 95% CI 1.5e3.9). We also noted the OR of nursing home
factors for those BSIs by P. aeruginosa and A. baumannii were 1.4
(95% CI 0.9e2.2) and 0.9 (95% CI 0.5e1.5), respectively, and they
were not statistically signiﬁcant.Table 4
Univariable and multivariable analysis of risk factors for selected resistant strains.
Variable Gram(þ)
MRSA MRCNS
(n¼ 206) (n¼ 130)
n OR (95% CI) n OR (95% CI)
Univariable analysis
Age, year 0.994a (0.975-1.014) 1.029 (1.005-1.053)
Sex (male) 109 1.1 (0.8-1.5) 67 1.0 (0.7-1.5)
Nursing home 82 1.7 (1.3-2.3) 58 2.1 (1.5-3.0)
Hospital exposure factor
within 48hrs of hospitalization 46 1.0 56 1.0
within 48hrs, re-hospitalizationb 33 2.6 (1.6-4.2) 31 2.0 (1.2-3.2)
after 48hrs of hospitalization 127 3.1 (2.2-4.4) 43 0.8 (0.5-1.1)
End-stage renal disease 46 3.1 (2.2-4.5) 14 1.1 (0.6-2.0)
Diabetes mellitus 101 1.6 (1.2-2.2) 55 1.2 (0.8-1.7)
Bedridden 89 1.7 (1.3-2.3) 62 2.0 (1.4-2.9)
Stroke 83 1.3 (1.0-1.8) 64 1.9 (1.3-2.8)
Liver cirrhosis 13 0.8 (0.5-1.5) 5 0.5 (0.2-1.2)
Solid organ malingnancy 57 0.9 (0.7-1.3) 27 0.6 (0.4-1.0)
Hematologic tumor 3 1.0 (0.3-3.5) 0 e
Chemotherapy 4 0.4 (0.1-1.1) 3 0.5 (0.2-1.6)
Multivariable analysis
Nursing home 2.0 (1.5-2.8) 1.7 (1.2-2.5)
Hospital exposure factor
within 48hrs of hospitalization 1.0 1.0 1.0 1.0
within 48hrs, re-hospitalizationb 2.5 (1.6-4.1) 2.0 (1.2-3.1)
after 48hrs of hospitalization 3.3 (2.3-4.7) 0.9 (0.6-1.4)
End-stage renal disease 2.3 (1.5-3.4) e
1.4 (1.1-1.9) e
Bedridden e e
Stroke e 1.6 (1.1-2.4)
Abbreviations : MRSA , Methicilli n-resistant Staphylococcus aureus ; MRCNS , Me
ß-lactamases.
a Analyze in continuous variable.
b Re-hospitalization was deﬁned as hospital admission within 30 days after discharge
c Enterobacteriaceae-ESBLs include: E. coli, Enterobactercloacae, Klebsiella pneumoniae,Notably, the effect of hospitalization within 30 days signiﬁ-
cantly added to the risk for BSIs by all of the selected ARB, except
ESBL-producing Enterobacteriaceae (OR 1.2, 95% CI 0.6e2.3). As to
the subgroup of BSIs within 48 h after hospital admission, the ORs
by all but MRCNS (OR 0.9, 95% CI 0.6e1.4) were also signiﬁcantly
higher.
To further evaluate the intervariable effect between nursing
home and hospital exposure, we performed multivariable logistic
regression by assessing the nursing home effect in subgroups of
hospital exposure stratiﬁed according to the timeline of the BSIs
(Table 5), which was only signiﬁcant for BSIs caused by ESBL-
producing Enterobacteriaceae with a reduction of deviance of 6.9
with two degrees of freedom (p< 0.05). In patients with bacteremia
occurring within 48 h of admission or those who were rehospi-
talized within 30 days, nursing home exposure signiﬁcantly raisedGram(-)
P. aeruginosa Enterobacteriaceae-ESBLsc A. baumannii
(n¼ 93) (n¼ 98) (n¼ 90)
n OR (95% CI) n OR (95% CI) n OR (95% CI)
1.001 (0.974-1.030) 1.037 (1.009-1.065) 1.003 (0.975-1.032)
52 1.3 (0.8-1.9) 45 0.8 (0.5-1.2) 51 1.3 (0.8-2.0)
29 1.1 (0.7-1.8) 50 2.7 (1.8-4.1) 17 0.6 (0.3-1.0)
13 1.0 34 1.0 2 1.0
17 4.6 (2.2-9.7) 13 1.3 (0.7-2.5) 6 10.3 (2.1-51.4)
63 5.2 (2.8-9.5) 51 1.5 (1.0-2.4) 82 45.8 (11.2-186.8)
12 1.4 (0.7-2.6) 12 1.3 (0.7-2.4) 16 2.1 (1.2-3.6)
37 1.1 (0.7-1.6) 44 1.3 (0.9-2.0) 38 1.2 (0.8-1.8)
36 1.3 (0.9-2.1) 52 2.5 (1.6-3.7) 25 0.8 (0.5-1.3)
27 0.8 (0.5-1.2) 45 1.7 (1.1-2.5) 23 0.6 (0.4-1.0)
4 0.6 (0.2-1.5) 5 0.7 (0.3-1.7) 11 1.8 (0.9-3.5)
39 1.8 (1.2-2.8) 26 0.9 (0.6-1.4) 34 1.5 (1.0-2.3)
2 1.5 (0.4-6.7) 0 e 0 e
7 1.8 (0.8-4.0) 2 0.4 (0.1-1.8) 8 2.2 (1.0-4.7)
1.4 (0.9-2.2) 2.4 (1.5-3.9) 0.9 (0.5-1.5)
1.0
4.6 (2.2-9.6) 1.2 (0.6-2.3) 10.4 (2.1-51.8)
5.5 (3.0-10.2) 1.9 (1.2-2.9) 44.8 (11.0-183.2)
e e e
e e e
e 1.8 (1.1-2.8) e
e e e
thicillin-resistant coagulase-negative Staphylococcus; ESBLs, Extended spectrum
from last hospitalization.
Proteus mirabilis.
Table 5
The role of nursing home factor and it’s interaction with hosiptal exposure for selected resistant strains.
Gram(þ) Gram(-)
MRSA MRCNS P. aeruginosa Enterobacteriaceae-ESBLsa A. baumannii
(n¼ 206) (n¼ 130) (n¼ 93) (n¼ 98) (n¼ 90)
Overall nursing home effect
Nursing home exposure 82 58 29 50 17
Non-exposure 124 72 64 48 73
OR (95% CI) 2.0 (1.5-2.8)c 1.7 (1.2-2.5)d 1.4 (0.9-2.2)e 2.4 (1.5-3.9)f 0.9 (0.5-1.5)e
Interaction term between nursing home and hospital exposure p¼ 0.139 p¼ 0.331 p¼ 0.656 p< 0.05 p¼ 0.654
Nursing home effect in stratiﬁed hospital exposure
within 48hrs of hospitalization
Nursing home exposure 28 31 7 24 1
Non-exposure 18 25 6 10 1
OR (95% CI) 2.9 (1.6-5.3)c 2.2 (1.3-3.8)d 2.2 (0.7-6.6)e 3.8 (1.8-8.2)f 1.9 (0.1-29.8)e
within 48hrs, re-hospitalizationb
Nursing home exposure 14 17 8 11 3
Non-exposure 19 14 9 2 3
OR (95% CI) 1.1 (0.5-2.3)c 1.7 (0.8-3.7)d 1.3 (0.5-3.6)e 7.1 (1.5-33.1)f 1.5 (0.3-7.6)e
after 48hrs of hospitalization
Nursing home exposure 40 10 14 15 13
Non-exposure 87 33 49 36 69
OR (95% CI) 2.1 (1.3-3.2)c 1.1 (0.5-2.3)d 1.2 (0.7-2.3)e 1.4 (0.7-2.7)f 0.8 (0.4-1.4)e
Abbreviations: MRSA, Methicillin-resistant Staphylococcus aureus; MRCNS, Methicillin-resistant coagulase-negative Staphylococcus; ESBLs, Extended spectrum ß-lactamases.
a Enterobacteriaceae-ESBLs include: E. coli, Enterobacter cloacae, Klebsiella pneumoniae, Proteus mirabilis.
b Re-hospitalization was deﬁned as hospital admission within 30 days after discharge from last hospitalization.
c adjusted varible included DM, ESRD and hospital exposure factor.
d adjusted for Stroke and hospital exposure factor..
e adjusted only for hospital exposure factor.
f adjusted variable included hospital exposure factor and Bedridden.
M.-Y. Huang et al.98the risk for acquiring EnterobacteriaceaeeESBL-related BSIs by the
ORs of 3.8 (95% CI 1.8e8.2) and 7.1 (95% CI 1.5e33.1), respectively.
4. Conclusion
In the literature the deﬁnition of a history of recent hospital
exposure is somewhat subjective and lacks unanimity. Various
deﬁnitions have been proposed, ranging from 30 days to 90
days5e7,18,19 to even as far as 1 year20,21. The longer the duration in
the deﬁnition of recent hospital admission deﬁned as health-care
associated, the lower the number of drug-resistant organisms
classiﬁed as community associated. We applied the 30-day dura-
tion as the cutoff point for the deﬁnition of recent hospitalization,
for reasons of clinical practicality and because a longer period is
not necessarily associated with a lower number of community-
acquired drug-resistant pathogens. Chi et al21 illustrated this
phenomenon and discovered that the prevalence of MRSA BSIs
among community-acquired S. aureus BSIs, by subtracting episodes
of recent hospitalization within a 1-year period from recent
admissionwas 33.7%, which was higher than the prevalence of 26%
with the 30-day period used in a study by Lin et al19.
In our study, both end-stage renal disease and diabetes mellitus
were shown to be risks associated with MRSA BSIs, while BSIs by
MRCNS and Enterobacteriaceae-ESBLs were closely linked to the
presence of stroke events and bedridden status, respectively. Yet,
our study could not identify any medical disease as a risk factor for
P. aeruginosa and A. baumannii BSIs. As a matter of fact, environ-
mental factors were shown to have an even more potentially
signiﬁcant effect on all the antimicrobial-resistant pathogens. This
is an interesting point that might deserve further exploration.
We discovered an interesting trend while analyzing the data.
When grouping all the BSIs according to nursing home history and
recent and current hospital exposure status, we separated all into
ﬁve groups. Interestingly, the environmental effect of nursing
home and hospital exposure exhibits an upward slope from thenNH group to the NH group and, ﬁnally, the HA group, while
showing an incremental effect, or rather, an accumulative dose
effect, for acquiring certain resistant pathogens, especially MRSA,
P. aeruginosa and A. baumannii (Fig. 2A). In other words, environ-
mental factors not only inﬂuence the strains of pathogens in BSIs, but
also are additive and cumulative in terms of prevalence and likeli-
hood of acquiring those three speciﬁc pathogens. Several investiga-
tions have demonstrated exposure to a nursing home environment
as an independent risk factor for MRSA BSIs18,20,22e24, whereas the
debate on risk to nursing home residents of P. aeruginosa infection
has continued for decades. Cheong et al13 suggested healthcare-
associated factor are an independent predictor for P. aeruginosa
infection; however, their patients with “healthcare-associated”
infections included but were not strictly limited to patients from
long-term care facilities. Moreover, a recent case-control study by
Schechner et al25 agreed with the ﬁnding of our study, showing no
signiﬁcant association between nursing home exposure and
P. aeruginosa BSIs. Notably, our study did ﬁnd a trend, though not
signiﬁcant, in the risk of acquiring BSIs by P. aeruginosa in nursing
home patients.
On the other hand, our data revealed a different pattern for BSIs
by MRCNS and ESBL-producing Enterobacteriaceae (Fig 2B). By
plotting data onto a graph, a deﬁnite elevation was seen in the NH
and the NH-reH groups compared with the other three groups,
depicting a distinct M-shape in the plot. This result suggests that
long-term care facilities are an important risk factor in acquiring
those two pathogens, while recent hospitalization and the status of
current admission are less likely to be risk factors. This interesting
ﬁnding deserves attention.
Nicolas-Chanoine et al17 recently reported a 9-year surveillance
survey of ESBL-producing isolates in 39 short-term-care and
eight long-term-care facilities in France. They found the incidence
of Enterobacteriaceae-ESBL infections was four-times higher in
2005 than in 1996. This raises the concern for the rapid emergence
of ESBL-producing Enterobacteriaceae in the nursing home
Nursing Homes and Antimicrobial-Resistant Bacteria 99environment. In 1996, Schiappa et al26 described the signiﬁcant risk
of nursing home exposure on ESBL-producing Enterobacteriaceae
infections, with an OR of 3.6; whereas our current study showed
a similar result, with an OR of 2.4. Meanwhile, a study conducted
by Wiener et al27 found that among 55 positive cultures of
ceftazidime-resistant E. coli, K. pneumoniae or both, the vast
majority were from long-term care facilities (31/55). All these
reports highlight the special concern regarding either infection or
colonization of ESBL-producing Enterobacteriaceae among nursing
home patients.
Similarly, the strong correlation between MRCNS infections and
long-term care facilities has been addressed. Our study showed
that although traditionally classiﬁed as a part of nosocomial
infections28, bacteremia of coagulase-negative Staphylococcus are
closely linked with exposure to nursing homes and recent hospi-
talization. Other studies support this result. Lee et al29 examined
the incidence of colonization of MRCNS in the nostrils of nursing
home residents, and MRCNS was found to be colonized in 40% of
patients and 60% of medical personnel compared with 13% of the
control group. The prevalence was even higher among debilitated
patients with limited motility. Signiﬁcantly, a follow-up report of
the study demonstrated the incidence of MRCNS colonization
correlated with the length of stay in long-term care facilities; the
longer one stayed, the more likely one would acquire MRCNS
colonization, from an average of 21% initially increasing to 59% after
a period of 17 months. This phenomenon might account for the
distinctly high incidence ofMRCNS BSIs among residents from long-
term care facilities.
Our study has also identiﬁed E. coli as the most common
overall organism in BSI patients from nursing homes, which is in
agreement with most previous reports6,30e33. Furthermore, the
most common nursing-home-associated gram-positive bacterium
isolated in our study was MRCNS, which corresponds with results
proposed by Khayr et al11. In addition, the proportion of nursing-
home-associated BSIs caused by MRSA, P. aeruginosa, and
A. baumannii were also similar to previous reports. However, on
further risk analysis, the relationship was not signiﬁcant between
nursing home exposure and BSIs caused by P. aeruginosa and
A. baumannii, while it signiﬁcantly increased the risk for BSIs
caused by MRSA, MRCNS, and ESBL-producing Enterobacteriaceae,
by adjusted ORs of 2.0, 1.7, and 2.4, respectively.
In conclusion, host environment remains the major factor
for acquiring antimicrobial-resistant pathogens, and, even more
interesting, this study demonstrated that different pathogens
interacted differently with each individual environmental factor.
In addition, environmental factors in our study (nursing home
facility and recent and current hospital exposure) seemed to exert
cumulative effects toward MRSA, P. aeruginosa, and A. baumannii,
while long-term care facilities seemed strongly inﬂuential for
MRCNS and ESBL-producing Enterobacteriaceae. Finally, our study
demonstrated that each unique environment increased the risk
for acquiring some pathogens, but not all. Options for the treat-
ment of infections by antimicrobial-resistant pathogens were
limited and adverse outcomes ensue from delayed treatment.
Findings in our study may help emergency physicians in selecting
antimicrobial agents for nursing home patients with suspected
BSIs.
5. Limitations
As in many retrospective studies, ours has inherent shortcom-
ings. Although missing medical records were limited compared to
the large numbers in our study, data recorded in medical charts
may not be complete, especially regarding the sources of infection,
courses of treatment, and causes of mortality. Hence, we did notattempt to analyze data in terms of source of infection and outcome
because of the potential bias from incomplete medical records.
Second, microbiological data may differ due to geographical
differences, and this study only refers to patients in a single
hospital. Although the pattern of microbiological distribution in our
study was similar to reports from other countries, the rate of
antimicrobial resistance among pathogens differs markedly
between countries. However, we believe that the nursing home
environment served as an important reservoir for certain drug-
resistant microorganisms universally. Finally, the low yield rate of
current bacteriologic methods makes our study underestimate the
true BSI episodes in clinical settings. It is understandable that all
studies on bacteremia will face this limitation. As a result, applying
our conclusions to clinically septic patients with negative blood
culture results should be done with care.References
1. Cosgrove SE, Sakoulas G, Perencevich EN, et al. Comparison of mortality
associated with methicillin-resistant and methicillin-susceptible Staphylo-
coccus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003;36:53e59.
2. Blot SI, Vandewoude KH, Hoste EA, et al. Outcome and attributable mortality
in critically Ill patients with bacteremia involving methicillin-susceptible and
methicillin-resistant Staphylococcus aureus. Arch Intern Med. 2002;162:
2229e2235.
3. Richardson JP, Hricz L. Risk factors for the development of bacteremia in
nursing home patients. Arch Fam Med. 1995;4:785e789.
4. Doshi RK, Patel G, Mackay R, et al. Healthcare-associated infections: epidemi-
ology, prevention, and therapy. Mt Sinai J Med. 2009;76:84e94.
5. Valles J, Calbo E, Anoro E, et al. Bloodstream infections in adults: importance of
healthcare-associated infections. J Infect. 2008;56:27e34.
6. Siegman-Igra Y, Fourer B, Orni-Wasserlauf R, et al. Reappraisal of community-
acquired bacteremia: a proposal of a new classiﬁcation for the spectrum of
acquisition of bacteremia. Clin Infect Dis. 2002;34:1431e1439.
7. Friedman ND, Kaye KS, Stout JE, et al. Health care-associated bloodstream
infections in adults: a reason to change the accepted deﬁnition of community-
acquired infections. Ann Intern Med. 2002;137:791e797.
8. Mylotte JM, Mylotte JM. Nursing home-acquired bloodstream infection. Infect
Control Hosp Epidemiol. 2005;26:833e837.
9. High KP, Bradley SF, Gravenstein S, et al. Clinical practice guideline for the
evaluation of fever and infection in older adult residents of long-term care
facilities: 2008 update by the Infectious Diseases Society of America. Clin Infect
Dis. 2009;48:149e171.
10. Chen SY, Wu GH, Chang SC, et al. Bacteremia in previously hospitalized
patients: prolonged effect from previous hospitalization and risk factors
for antimicrobial-resistant bacterial infections. Ann Emerg Med. 2008;51:
639e646.
11. Khayr WF, CarMichael MJ, Dubanowich CS, et al. Bacteremia in veterans
administration nursing home patients. Am J Ther. 2004;11:251e257.
12. Chiang WC, Chen SY, Chien KL, et al. Predictive model of antimicrobial-resistant
gram-negative bacteremia at the ED. Am J Emerg Med. 2007;25:597e607.
13. Cheong HS, Kang CI, Wi YM, et al. Clinical signiﬁcance and predictors of
community-onset Pseudomonas aeruginosa bacteremia. Am J Med. 2008;121:
709e714.
14. Horan TC, Andrus M, Dudeck MA, et al. CDC/NHSN surveillance deﬁnition of
health care-associated infection and criteria for speciﬁc types of infections in
the acute care setting. Am J Infect Control. 2008;36:309e332.
15. JS G, WR J, TG E, et al. CDC deﬁnitions for nosocomial infections. In:
Olmsted RN, editor. APIC infection control and applied epidemiology: principles
and practice. St. Louis: Mosby; 1996:A-1.20.
16. Arpin C, Dubois V, Coulange L, et al. Extended-spectrum beta-lactamase-
producing Enterobacteriaceae in community and private health care centers.
Antimicrob Agents Chemother. 2003;47:3506e3514.
17. Nicolas-Chanoine MH, Jarlier V. ’La Collégialé de Bactériologie-Virologie-
Hygiène Hospitalière de l’Assistance Publique, Hôpitaux de Paris, France.
Extended-spectrum beta-lactamases in long-term-care facilities. Clin Microbiol
Infect. 2008;14(Suppl. 1):111e116.
18. McHugh CG, Riley LW, McHugh CG, et al. Risk factors and costs associated with
methicillin-resistant Staphylococcus aureus bloodstream infections. Infect
Control Hosp Epidemiol. 2004;25:425e430.
19. Lin JC, Yeh KM, Peng MY, et al. Community-acquired methicillin-resistant
Staphylococcus aureus bacteremia in Taiwan: risk factors for acquisition,
clinical features and outcome. J Microbiol Immunol Infect. 2004;37:24e28.
20. Liao CH, Chen SY, Chang SC, et al. Characteristics of community-acquired and
health care-associated Staphylococcus aureus bacteremia in patients treated at
the emergency department of a teaching hospital. Diagn Microbiol Infect Dis.
2005;53:85e92.
21. Chi CY, Wong WW, Fung CP, et al. Epidemiology of community-acquired
Staphylococcus aureus bacteremia. J Microbiol Immunol Infect. 2004;37:16e23.
M.-Y. Huang et al.10022. Libert M, Elkholti M, Massaut J, et al. Risk factors for meticillin resistance and
outcome of Staphylococcus aureus bloodstream infection in a Belgian univer-
sity hospital. J Hosp Infect. 2008;68:17e24.
23. Jernigan JA, Pullen AL, Flowers L, et al. Prevalence of and risk factors for
colonization with methicillin-resistant Staphylococcus aureus at the time of
hospital admission. Infect Control Hosp Epidemiol. 2003;24:409e414.
24. Lodise TP Jr, McKinnon PS, Rybak M, et al. Prediction model to identify patients
with Staphylococcus aureus bacteremia at risk for methicillin resistance. Infect
Control Hosp Epidemiol. 2003;24:655e661.
25. Schechner V, Nobre V, Kaye KS, et al. Gram-negative bacteremia upon hospital
admission: when should Pseudomonas aeruginosa be suspected? Clin Infect
Dis. 2009;48:580e586.
26. Schiappa DA, Hayden MK, Matushek MG, et al. Ceftazidime-resistant Klebsiella
pneumoniae and Escherichia coli bloodstream infection: a case-control and
molecular epidemiologic investigation. J Infect Dis. 1996;174:529e536.
27. Wiener J, Quinn JP, Bradford PA, et al. Multiple antibiotic-resistant Klebsiella
and Escherichia coli in nursing homes. JAMA. 1999;281:517e523.28. Akpaka PE, Christian N, Bodonaik NC, et al. Epidemiology of coagulase-negative
Staphylococci isolated from clinical blood specimens at the University Hospital
of the West Indies. West Indian Med J. 2006;55:170e173.
29. Lee YL, Cesario T, Tran C, et al. Nasal colonization by methicillin-resistant
coagulase-negative staphylococcus in community skilled nursing facility
patients. Am J Infect Control. 2000;28:269e272.
30. Mylotte JM, Tayara A, Goodnough S, et al. Epidemiology of bloodstream
infection in nursing home residents: evaluation in a large cohort from multiple
homes. Clin Infect Dis. 2002;35:1484e1490.
31. Sinclair D, Svendsen A, Marrie T. Bacteremia in nursing home patients. Prev-
alence among patients presenting to an emergency department. Can Fam
Physician. 1998;44:317e322.
32. Muder RR, Brennen C, Wagener MM, et al. Bacteremia in a long-term-care
facility: a ﬁve-year prospective study of 163 consecutive episodes. Clin Infect
Dis. 1992;14:647e654.
33. Setia U, Serventi I, Lorenz P. Bacteremia in a long-term care facility. Spectrum
and mortality. Arch Intern Med. 1984;144:1633e1635.
